Interferon-alpha Leukoferon - Viragen

Drug Profile

Interferon-alpha Leukoferon - Viragen

Alternative Names: Alpha Leukoferon

Latest Information Update: 19 Nov 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Viragen
  • Class Antineoplastics; Antivirals; Interferons
  • Mechanism of Action Interferon alpha stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; HIV infections; Multiple sclerosis

Most Recent Events

  • 01 Aug 1995 Discontinued-Clinical for Cancer in USA (Injection)
  • 01 Aug 1995 Discontinued-Clinical for HIV infections treatment in USA (Injection)
  • 01 Aug 1995 Discontinued-Clinical for Multiple sclerosis in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top